Invisalign Expander for Palate Expansion
What You Need to Know Before You Apply
What is the purpose of this trial?
The aim of this study is to evaluate the effectiveness of Invisalign Palatal Expander system ingrowing patients. This study compares the treatment outcomes of Invisalign Palatal Expander system to conventional treatments through randomized controlled trial.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Is the Invisalign Expander for Palate Expansion safe for humans?
The research on palatal expanders, including those similar to the Invisalign Expander, suggests that they generally result in successful expansion without significant problems or complications. However, some studies mention potential discomfort, speech impairment, and chewing difficulty during initial adaptation.12345
How is the Invisalign Palatal Expander System treatment different from other palate expansion treatments?
The Invisalign Palatal Expander System is unique because it likely offers a more discreet and comfortable option for palate expansion compared to traditional expanders, which can affect speech and require attachments cemented to the teeth. This system may use clear aligner technology, similar to other Invisalign products, providing a less invasive and more aesthetically pleasing alternative.16789
Who Is on the Research Team?
Heeyeon Suh
Principal Investigator
University of the Pacific
Are You a Good Fit for This Trial?
This trial is for patients with a narrow upper jaw presenting as unilateral or bilateral posterior crossbite, who are in the mixed or early permanent dentition phase without fully erupted second molars. Participants must have stable teeth and be willing to consent. Those with craniofacial anomalies, Class III skeletal profile, or significant health issues affecting treatment are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the Invisalign Palatal Expander System or the Hyrax-type maxillary expander
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Invisalign Palatal Expander System
Invisalign Palatal Expander System is already approved in European Union for the following indications:
- Skeletal and dental expansion in growing patients
- Orthodontic treatment of malocclusion
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of the Pacific
Lead Sponsor